US BROKER MOVES: AMD upgraded at Oppenheimer; DKNG downgraded at numerous brokerages
ORIGINAL · NewsquawkUS BROKER MOVES: AMD upgraded at Oppenheimer; DKNG downgraded at numerous brokeragesRead originalHide original
UPGRADES Airbnb (ABNB) Upgraded from Sell to Neutral at Rothschild Redburn; PT USD 190 AMD (AMD) Upgraded from Perform to Outperform at Oppenheimer; PT USD 600 DNOW (DNOW) Upgraded from Hold to Buy at Freedom Broker; PT USD 18 Innovative Industrial Properties (IIPR) Upgraded from Neutral to Buy at Alliance Global Partners; PT USD 64 Rollins (ROL) Upgraded from Neutral to Buy at Citi; PT USD 49 Sanofi (SNY) Upgraded from Neutral to Outperform at BNP Paribas Exane; PT USD 57 Treace Medical Concepts (TMCI) Upgraded from Hold to Buy at Stifel; PT USD 6.50 Tripadvisor (TRIP) Upgraded from Underperform to Hold at Jefferies; PT USD 7 Tronox (TROX) Upgraded from Underweight to Neutral at JPMorgan Unum (UNM) Upgraded from Neutral to Overweight at JPMorgan; PT USD 90 DOWNGRADES Amrize (AMRZ) Downgraded from Buy to Hold at Berenberg; PT USD 46 Beta Technologies (BETA) Downgraded from Buy to Hold at Jefferies; PT USD 27 DraftKings (DKNG) Downgraded from Overweight to Neutral at JPMorgan; PT USD 21 DraftKings (DKNG) Downgraded from Buy to Hold at Stifel; PT USD 21 DraftKings (DKNG) Downgraded from Buy to Neutral at UBS; PT USD 22 Installed Building Products (IBP) Downgraded from Buy to Hold at Stifel; PT USD 225 IREN (IREN) Downgraded from Outperform to Neutral at CCB International Lyft (LYFT) Downgraded from Outperform to Equalweight at Fox Advisors Nvidia (NVDA) Downgraded from Buy to Hold at Aletheia Capital Neighborhood Intelligence (NXH) Downgraded from Buy to Hold at Maxim Group PDD Holdings (PDD) Downgraded from Overweight to Equalweight at Morgan Stanley; PT USD 90 Molson Coors (TAP) Downgraded from Neutral to Underweight at JPMorgan; PT USD 37 TransUnion (TRU) Downgraded from Buy to Neutral at Rothschild Redburn; PT USD 91 Zillow (ZG) Downgraded from Overweight to Sector Weight at KeyBanc INITIATIONS Bullish (BLSH) Initiated at Buy at StoneX; PT USD 42 Black Rock Coffee Bar (BRCB) Initiated at Hold at Stifel; PT USD 12 Dutch Bros (BROS) Initiated at Buy at Stifel; PT USD 48 Hemab Therapeutics (COAG) Initiated at Outperform at LifeSci Capital; PT USD 65 Idaho Copper (COPR) Initiated at Buy at ThinkEquity; PT USD 8 Camping World (CWH) Initiated at Overweight at Wells Fargo; PT USD 6 Eupraxia Pharmaceuticals (EPRX) Initiated at Outperform at RBC Capital; PT USD 14 Graham Corporation (GHM) Initiated at Outperform at William Blair Iambic Therapeutics (IAM) Initiated at Buy at BofA Securities; PT USD 30 Iambic Therapeutics (IAM) Initiated at Buy at Citi; PT USD 22 Iambic Therapeutics (IAM) Initiated at Overweight at JPMorgan; PT USD 22 Disc Medicine (IRON) Initiated at Buy at Guggenheim; PT USD 132 Kailera Therapeutics (KLRA) Initiated at Buy at Canaccord; PT USD 44 L3Harris (LHX) Initiated at Buy at Citi; PT USD 348 Patrick Industries (PATK) Initiated at Overweight at Wells Fargo; PT USD 95 Parabilis Medicines (PBLS) Initiated at Buy at Canaccord; PT USD 39 Starbucks (SBUX) Initiated at Buy at Stifel; PT USD 115 Solid Biosciences (SLDB) Initiated at Outperform at William Blair Supernus Pharmaceuticals (SUPN) Initiated at Buy at BofA Securities; PT USD 47 Thor Industries (THO) Initiated at Equal Weight at Wells Fargo; PT USD 80 United Therapeutics (UTHR) Initiated at Buy at H.C. Wainwright; PT USD 660 Winnebago Industries (WGO) Initiated at Underweight at Wells Fargo; PT USD 27
The November 9 roundup lists broker upgrades, downgrades and initiations, including three DraftKings downgrades and three Iambic Therapeutics initiations.
News detail
UPGRADES Airbnb (ABNB) Upgraded from Sell to Neutral at Rothschild Redburn; PT USD 190 AMD (AMD) Upgraded from Perform to Outperform at Oppenheimer; PT USD 600 DNOW (DNOW) Upgraded from Hold to Buy at Freedom Broker; PT USD 18 Innovative Industrial Properties (IIPR) Upgraded from Neutral to Buy at Alliance Global Partners; PT USD 64 Rollins (ROL) Upgraded from Neutral to Buy at Citi; PT USD 49 Sanofi (SNY) Upgraded from Neutral to Outperform at BNP Paribas Exane; PT USD 57 Treace Medical Concepts (TMCI) Upgraded from Hold to Buy at Stifel; PT USD 6.50 Tripadvisor (TRIP) Upgraded from Underperform to Hold at Jefferies; PT USD 7 Tronox (TROX) Upgraded from Underweight to Neutral at JPMorgan Unum (UNM) Upgraded from Neutral to Overweight at JPMorgan; PT USD 90 DOWNGRADES Amrize (AMRZ) Downgraded from Buy to Hold at Berenberg; PT USD 46 Beta Technologies (BETA) Downgraded from Buy to Hold at Jefferies; PT USD 27 DraftKings (DKNG) Downgraded from Overweight to Neutral at JPMorgan; PT USD 21 DraftKings (DKNG) Downgraded from Buy to Hold at Stifel; PT USD 21 DraftKings (DKNG) Downgraded from Buy to Neutral at UBS; PT USD 22 Installed Building Products (IBP) Downgraded from Buy to Hold at Stifel; PT USD 225 IREN (IREN) Downgraded from Outperform to Neutral at CCB International Lyft (LYFT) Downgraded from Outperform to Equalweight at Fox Advisors Nvidia (NVDA) Downgraded from Buy to Hold at Aletheia Capital Neighborhood Intelligence (NXH) Downgraded from Buy to Hold at Maxim Group PDD Holdings (PDD) Downgraded from Overweight to Equalweight at Morgan Stanley; PT USD 90 Molson Coors (TAP) Downgraded from Neutral to Underweight at JPMorgan; PT USD 37 TransUnion (TRU) Downgraded from Buy to Neutral at Rothschild Redburn; PT USD 91 Zillow (ZG) Downgraded from Overweight to Sector Weight at KeyBanc INITIATIONS Bullish (BLSH) Initiated at Buy at StoneX; PT USD 42 Black Rock Coffee Bar (BRCB) Initiated at Hold at Stifel; PT USD 12 Dutch Bros (BROS) Initiated at Buy at Stifel; PT USD 48 Hemab Therapeutics (COAG) Initiated at Outperform at LifeSci Capital; PT USD 65 Idaho Copper (COPR) Initiated at Buy at ThinkEquity; PT USD 8 Camping World (CWH) Initiated at Overweight at Wells Fargo; PT USD 6 Eupraxia Pharmaceuticals (EPRX) Initiated at Outperform at RBC Capital; PT USD 14 Graham Corporation (GHM) Initiated at Outperform at William Blair Iambic Therapeutics (IAM) Initiated at Buy at BofA Securities; PT USD 30 Iambic Therapeutics (IAM) Initiated at Buy at Citi; PT USD 22 Iambic Therapeutics (IAM) Initiated at Overweight at JPMorgan; PT USD 22 Disc Medicine (IRON) Initiated at Buy at Guggenheim; PT USD 132 Kailera Therapeutics (KLRA) Initiated at Buy at Canaccord; PT USD 44 L3Harris (LHX) Initiated at Buy at Citi; PT USD 348 Patrick Industries (PATK) Initiated at Overweight at Wells Fargo; PT USD 95 Parabilis Medicines (PBLS) Initiated at Buy at Canaccord; PT USD 39 Starbucks (SBUX) Initiated at Buy at Stifel; PT USD 115 Solid Biosciences (SLDB) Initiated at Outperform at William Blair Supernus Pharmaceuticals (SUPN) Initiated at Buy at BofA Securities; PT USD 47 Thor Industries (THO) Initiated at Equal Weight at Wells Fargo; PT USD 80 United Therapeutics (UTHR) Initiated at Buy at H.C. Wainwright; PT USD 660 Winnebago Industries (WGO) Initiated at Underweight at Wells Fargo; PT USD 27
Related stocks
43 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
